Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis (SELECTION1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02914522

Recruitment Status : Completed

First Posted : September 26, 2016

Last Update Posted : May 4, 2020

Sponsor:

Collaborator:

Galapagos NV

Information provided by (Responsible Party):

Gilead Sciences

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	March 31, 2020
Actual Study Completion Date :	March 31, 2020

To Top